FDA Investigator Grace P Santos
Grace P Santos has inspections in 1 countries as of 16 Nov 2023. Grace P Santos has collaborated with a combinined 3335 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
101
Last Inspection Date:
16 Nov 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
Aimee K Contreras,
Alexandra B Pitkin,
Amir Alavi,
Ana Djurdjevic,
Andrew R Wasko,
Angela Shepas,
Angelica G Aziz,
Anita Narula, PhD,
Anna L Marroquin,
Annie H Lam,
April P Shaw,
Arsen Karapetyan,
Babajide Michael Osunsanmi,
Barbar J Breithaupt,
Barbara Janine Breithaupt,
Belinda E Clifton,
Bonnie I Needleman,
Bowman,
Brenda K Alford,
Bryan A Galvez,
Burnsb,
Bush,
Carl A Anderson,
Carol B Czerniak,
Carr Sharpe,
Cathleen A Carr Sharpe,
Celena Ngo,
Charles R Bonapace, PhD,
Chelsea N Sealey,
Cheron M Portee,
Chloe Anne K Le,
Christina D Mello,
Christine M Parmentier,
Comyar Shoghi,
Connie P Rezendes,
Corey A Cruse,
Creighton T Tuzon,
Ct Viswanathan, PhD,
Da Lin Yao, MD, PhD,
Daniel C Geffin,
Daniel J Roberts,
Darrin E Davis,
David G Whitman,
David Serrano,
David Y Hernandez,
Davis,
Deborah G Park,
Debra J Fracassa,
Dejon N Harris,
Desiree C Iya,
Diane Cvan Leeuwen,
Diane R Weidley,
Donald B Mckechnie,
Donna Ltartaglino Besone,
Donna Mwilliams Hill,
Dr. Mark J Seaton, PhD,
Dr. Zhou Chen (nmi), MD PhD,
Dyana K Stone,
Ellen N Stewart,
Erica R Pomeroy,
Erin M Mcdowell,
Francisco,
Frank P Bianco,
Gabriel Craig,
Gam S Zamil,
Garciam,
Gavin W Pierce,
Gene D Arcy,
Greg K Keshishyan,
Heika R Bounds,
Heika R Tait,
Henry E Carrillo,
Herminio C Francisco,
Hoover,
Hugh M Mcclure, II,
Ingrid A Zambrana,
Ismael Garibay,
Jacqueline A O'shaughnessy, PhD,
James A Barreto,
James C Yee,
Jane M Kreis,
Jasmine Y Wang,
Jazmine M Welcher,
Jeff M Uriarte,
Jennifer Crumb,
Jennifer M Gogley,
Jinnie Kokiatkulkij,
John A Gonzalez,
John P Jorgensen,
Jolanna A Norton,
Jonathan K Dare,
Joseph C Yen,
Joseph S Fanelli,
Judy C Nepsa,
Julian C Hanson,
Ka L Wong,
Kacie M Crowther,
Karen D Phung,
Karen J Bak,
Kathryn A Krentz,
Kawshalya Pathiraja,
Kelvin X Sanders,
Kevin Lee,
Kevin N Tran,
Kevin T Gerrity,
Kimberly L Anderson,
Kimberly M Lichter,
Kirtida Patel,
Lakecha N Lewis,
Laurissa S Flowers,
Lija V Fellows,
Liming Zhang,
Linda S Leja,
Ling Yul Liu,
Lisa H Nakagawa,
Lisa Shin,
Lori J Silverstein,
Lorraine N Williams,
LT Mark A Chen, MPH,
Mageet,
Marco S Esteves,
Maria Pkelly Doggett, MBA,
Maurice M Sheehan,
Maxyne T Lam,
Melanie C Voges,
Michael D Garcia,
Michael D Staake,
Michael F Skelly, PhD,
Michael S Call,
Miyo M Saito,
Monica R Maxwell,
Morgan J Matthews,
Nancy E Byerly,
Natalie J Ayoub,
Naveen B Walker,
Ngoc T Le,
Nianna C Burns,
Nicholas J Lahey,
Patricia F Alberico,
Phal K Chhun,
Phillip J Sample,
Phillip L Toy,
Phung,
Raymond W Brullo,
Richard W Tubb,
Robert C Hoover,
Robert D Ogan,
Rochelle A Rolnik,
Rocio Guzman Velazquez,
Romero,
Ronald P Boyce,
Ruben G Abrajano,
Russell R La Claire,
Sandersk,
Santiago Gallardo Johnson,
Sarah A Hassas,
Savannah E Samp,
Scott J Matsuda,
Sean P Desbrow,
Sharon S Ho,
Sonia R Peterson,
State Agency,
Stephen G Mclane,
Steven E Porter, Jr,
Steven M Galvez,
Sundy Ven,
Sunitha K Rajaram, PhD,
Tamala P Magee,
Tammy Vasquez Hancock,
Tanya E Malais,
Tara L Stockton,
Tawny L Colling,
Terrance L Thomas,
Thanh M Andrews,
Thao T Kwan,
Timothy P Lafave,
Tonia L Sawyer,
Tony J Wu,
Trudy R Papson,
Trushani T Desai,
Tuan D Tran,
Vanessa R Muller,
Vashti E Bocker,
Vickie L Anderson,
Victoria L Morgan,
Vien Q Le,
Wayne L Jefferson,
William D Boden,
William J Weis,
William S Vitale,
Yen Tso Kuo,
Yvette Mlacour Davis,
Yvonne C Wilkes,
Yvonne T Lacour,
Zachary A Bogorad,
Zachary R Harris
Grace P Santos's Documents
Publish Date | Document Type | Title |
---|---|---|
September, 2016 | FDA 483 | Cianna Medical, Inc. - Form 483, 2016-09-09 |
January, 2016 | FDA 483 | Synergy Health Concepts, Inc. - Form 483, 2016-01-28 |
January, 2017 | FDA 483 | Apinya B. Vutikullird, D.O. - Form 483, 2017-01-24 |
August, 2018 | FDA 483 | Health Plus Inc. - Form 483, 2018-08-16 |
July, 2023 | FDA 483 | Altasciences Preclinical Seattle, LLC - Form 483, 2023-07-14 |
January, 2016 | FDA 483 | Trelleborg Sealing Solutions US, Inc. - Form 483, 2016-01-08 |
April, 2019 | EIR | Loewy Enterprises, LLC - EIR, 2019-04-09 |
Experience Redica System's NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more